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To investigate the mechanisms underlying apoptosis in breast cancer cells, staurosporine was used as an apoptotic stimulus in
the human breast cancer cell lines MCF-7 and T47D. Staurosporine induced dose and time dependent increases in DNA
fragmentation which was abrogated by z-VAD-fmk. MCF-7 cells did not express caspase-3, suggesting that DNA
fragmentation occurred in the absence of caspase-3 and that other caspases may be involved. Staurosporine induced
DEVDase activity in T47D cells suggesting the involvement of caspase-3 and/or caspase-7, yet there was no DEVDase activity
in MCF-7 cells, probably ruling out the involvement caspase-7. However, staurosporine induced the cleavage of pro-caspase-6
in MCF-7 cells, but not in T47D cells. Caspase dependent PARP cleavage was detected in MCF-7 cells at 3 h, whereas only
partial PARP cleavage was detected in T47D cells and then only after 24 h. Moreover, staurosporine led to cytochrome c
release at 2 h in MCF-7 cells and 6 h in T47D cells. In addition, a time dependent and caspase-independent reduction of the
mitochondrial transmembrane potential was observed; which appeared to occur after the release of cytochrome c.
Translocation of Bax from the cytosol to mitochondria was observed in both cell types, and this preceded cytochrome c
release in both T47D and MCF-7 cells. Apoptotic events in both cell types differ temporally, involving activation of different
caspases and mitochondrial changes.
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Apoptosis is an essential process in both multi-cellular develop-
ment, and in maintaining cellular homeostasis. Moreover, failure
of damaged cells to undergo apoptosis contributes to the progres-
sion of cancer as it allows the persistence of DNA damaged cells. It
is therefore of interest to understand apoptotic signalling pathways
in different cancer types. Apoptosis is morphologically deﬁned by
cell shrinkage, membrane blebbing, chromatin condensation and
formation of apoptotic bodies. Central to the apoptotic process
is a family of cysteine proteases termed caspases which are crucial
effectors of this cell death process. Caspases exist in the cell as inac-
tive pro-enzymes that can be activated either by auto-catalytic
processing or by being activated by another caspase (Earnshaw et
al, 1999). These proteases can be classiﬁed into two groups: ‘initia-
tor’ caspases e.g. caspases-8 and -9, which have long prodomains at
the NH2-termini and have the ability to be self-cleaved on oligo-
merisation, and ‘effector’ caspases e.g. caspases-3, -6 and -7 that
have short prodomains and can be activated by initiator caspases
or by activated effector caspases (Thornberry and Lazebnik,
1998). Once activated by apoptotic stimuli, caspases contribute
to the morphological and biochemical changes of apoptosis by
catalysing the proteolysis and disabling of numerous key structural
and regulatory proteins within the cell such as, poly-ADP-ribose
polymerase (PARP), gelsolin, cytokeratins and DNA fragmentation
factor 45 kDa (DFF45) (Nunez et al, 1998).
The Bcl-2 family of anti- (Bcl-2, Bcl-xL, Mcl-1) and pro-apopto-
tic (Bax, Bad, Bid) proteins are also important in the regulation of
cell death. Bcl-2 family members have the ability to form homo-
and hetero-dimers and the ratio of anti- and pro-apoptotic
proteins may determine the fate of the cell (Reed, 1998). These
proteins can be either membrane bound or cytosolic. Bcl-2 has
been shown to be localised to the endoplasmic reticulum, mito-
chondrial membrane and the nuclear envelope (Krajewski et al,
1993), whereas other members such as Bax and Bid are mainly
cytosolic. However on induction of apoptosis, localisation of some
Bcl-2 family members alters. For example, Bax has been shown to
translocate from the cytosol to the mitochondrial membrane after
treatment with an apoptotic stimulus (Zhang et al, 1998), and
cause subsequent cytochrome c release and caspase activation.
Due to their diversity in function these proteins constitute an
important point of regulation in the apoptotic pathway.
An alteration in mitochondrial function has been demonstrated
to play a key role in the effector phase of the apoptotic pathway. A
reduction in the mitochondrial transmembrane potential (DCm)
and release of the mitochondrial protein cytochrome c is often
observed during apoptosis (Zamzami et al, 1995; Liu et al, 1996).
On induction of apoptosis cytochrome c is released from the inter-
membrane space into the cytoplasm where it leads to activation of
caspases and subsequent cell death (Liu et al, 1996). Mitochondrial
transmembrane potential breakdown is thought to be mediated by
the opening of a large conductance channel known as the mito-
chondrial permeability transition pore (PTP) (Zamzami et al,
1996). Studies have shown cytochrome c release to occur in the
absence of, or to precede DCm disruption (Bossy-Wetzel et al,
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chrome c release remains uncertain. The anti-apoptotic effect of
Bcl-2 and Bcl-xL has been shown to involve the prevention of cyto-
chrome c release and DCm loss whereas pro-apoptotic Bax can
induce these mitochondrial changes (Decaudin et al, 1997; Yang
et al, 1997; Jurgensmeier et al, 1998).
The order of apoptotic events appears to vary widely depending
on the cellular background and the apoptotic stimulus. It is, there-
fore, important to understand the molecular components of the
death machinery of the cell to aid the establishment of appropriate
therapeutic intervention. Indeed, caspase knock-out studies have
shown that not all caspases are essential for apoptosis (Zheng et
al, 1999). Caspase-3 has been shown to play a central role in key
apoptotic events such as DNA fragmentation and membrane bleb-
bing, and caspase-3 null mice die perinatally and display
hypercellularity (Woo et al, 1998). MCF-7 breast cancer cells also
lack caspase-3 protein, yet they remain responsive to many apop-
totic stimuli suggesting functional redundancy within the caspase
family (Janicke et al, 1998a). The present study was aimed at inves-
tigating the intracellular apoptotic signalling mechanisms in T47D
(caspase-3 positive) and MCF-7 (caspase-3 negative) breast cancer
cells in response to the general protein kinase inhibitor and apop-
totic stimulus, staurosporine (STS). We found that, in these two
similar solid tumour types, differences exist in the mechanisms
by which they undergo apoptosis. Our results show that the
mechanism of cell death was kinetically different with events occur-
ring earlier in MCF-7 cells, than in T47D cells. In addition, this
involved release of cytochrome c, a reduction in the mitochondrial
transmembrane potential (DCm) and activation of different
aspects of the caspase cascade.
MATERIALS AND METHODS
Materials
Staurosporine (STS) and z-VAD-fmk were from Alexis Biochem-
icals (Nottingham, UK). E. Coli. DNA polymerase 1 and all
culture media and sera were obtained from Gibco BRL (Paisley,
UK). The monoclonal mouse antibody against Bcl-2, the polyclonal
antibody against Bcl-xL and the polyclonal antibody to caspase-6
were obtained from Santa Cruz Biotechnology Inc., (California,
USA). The polyclonal rabbit antibody to Bax was purchased from
TCS Biologicals Ltd., (Buckingham, UK). PARP, Bak and cyto-
chrome c antibody were from Pharmingen (Oxford, UK). The
CaspACE Assay System, Colorimetric was from Promega, (South-
ampton, UK). The Cell death ELISA kit and protease cocktail
tablets were from Boehringer Mannheim, (East Sussex, UK). The
ECL system was obtained from Amersham, (Buckinghamshire,
UK).
Cell culture
T47D (ductal carcinoma) and MCF-7 (adenocarcinoma) human
breast cancer cell lines were maintained in Dulbecco’s Modiﬁed
Eagle’s Medium (DMEM) supplemented with 10% (v v
71) foetal
calf serum (FCS) and 2 mM glutamine. Cells were maintained at
378C in a humidiﬁed atmosphere of air/CO2 (19:1). Cells were
incubated with 1% FCS DMEM media during experimentation
for the times indicated.
In situ nick translation (ISNT)
Cells were incubated with staurosporine for different times in the
presence or absence of z-VAD-fmk. Adherent and detached cells
were pooled and were ﬁxed in 1% paraformaldehyde and permea-
bilized in 70% ethanol at 7208C. Cells were then washed in PBS
and incubated at room temperature for 4 h with nick translation
buffer (50 mM TRIS, 10 mgm l
71 bovine serum albumin (BSA),
2.5 mM MgCl2.6H2O, 10 mM b-mercaptoethanol) containing E.
Coli DNA polymerase (1 unit), 0.2 nM biotin-dUTP and 0.2 nM
each of dATP, dGTP and dCTP. Samples were washed and resus-
pended in staining buffer (600 mM NaCl, 60 mM sodium citrate,
0.1% Triton X-100, 5% non-fat dry milk (Marvel)) supplemented
with 2.5 mgm l
71 avidin-FITC. The samples were then washed and
analysed by Flow Cytometry. Aliquots of certain samples (100 ml)
were stained with 1 mgm l
71 4,6-diamidino-2-phenylindole
(DAPI), cytospun onto slides and visualised under a ﬂuorescent
microscope using IP Lab Spectrum Software (Signal Analytics,
Vienna, VA, USA) for apoptotic nuclear morphology.
DNA fragmentation ELISA (Boehringer Mannheim)
This assay measures cytoplasmic histone-bound DNA fragments
(mono- and oligonucleosomes) which are generated during apop-
tosis (Boehringer Mannheim). The enrichment of nucleosomes in
the cytoplasm of treated cells was expressed as fold induction in
apoptosis compared to untreated controls. Cells (1610
5) were
incubated with 1 mM STS, washed in PBS and then lysed in lysis
buffer for 30 min. The supernatant (cytoplasmic extract) was
recovered and the assay was performed according to the manufac-
turer’s protocol.
Annexin-V-FITC assay (BioSource International Inc)
Cells (5610
5) were treated with 1 mM STS for times indicated.
Adherent and detached cells were pooled, washed and then resus-
pended in binding buffer (buffer 10 mM HEPES/NaOH, pH 7.4,
140 mM NaCl, 2.5 mM CaCl2) and annexin-V-FITC antibody
(5 ml), mixed and incubated for 10 min at room temperature. Cells
were washed and resuspended in binding buffer containing propi-
dium iodide (PI) (10 ml) to give a ﬁnal concentration of 1 mgm l
71
PI prior to analysis by Flow Cytometry. Bivariant analysis of FITC-
ﬂuorescence (FL-1) and PI-ﬂuorescence (FL-3) gave different cell
populations where FITC 7ve and PI 7ve were designated as
viable cells; FITC +ve and PI 7ve phenotype as apoptotic cells,
and FITC +ve and PI +ve as late apoptotic or necrotic cells.
Caspase activity assay (Promega)
The CaspACE Assay System was utilised to detect DEVDase
(caspase-3/7) activity. Cells were treated with 1 mM STS and lysed
in lysis buffer from the kit. Protein content was determined and
lysates incubated with Ac-DEVD-pNA for 4 h at room tempera-
ture. The reaction product was detected at 405 nm using an
Athos 2001 automated plate reader (Athos Labtec Instruments,
UK).
Cytoﬂuorometric analysis of mitochondrial
transmembrane potential (DCm)
To measure DCm, cells (5610
5) were incubated with 40 nM 3,3-
dihexyloxacarbocyanine iodide (DiOC6(3)) for 20 mins at 378C.
As a positive control to show complete depletion of DCm, the
mitochondrial uncoupler, carbonyl cyanide m-chlorophenylhydra-
zone (CCCP at 50 mM) was used. Propidium Iodide (PI) was
added prior to FACS analysis as a measure of cell viability. Fluor-
escence of the total cell population was measured with DiOC6(3) at
green ﬂuorescence (FL-1) and PI at red ﬂuorescence (FL-3) by
FACScan using CellQuest software (Becton Dickinson).
Western blotting
Cells were treated with 1 mM STS for different periods of time, then
washed in ice cold PBS and lysed for 20 min on ice in lysis buffer
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71) NP-40,
0.625% sodium deoxycholate, 1 mM NaF, 1 mM Na3VO4,1
protease cocktail tablet (Boehringer Mannheim)). Equal amounts
of total protein (30 mg) were subjected to 14% (Bcl-2 family
proteins, cytochrome c and cytochrome c oxidase), 8% (Poly
ADP-Ribose Polymerase (PARP)) or 10% (caspase-6) SDS–PAGE
followed by Western transfer onto a PVDF membrane. Membranes
were incubated with antibodies against Bcl-2, Bax, Bak and Bcl-xL,
PARP, caspase-6 or cytochrome c and detected with the appropri-
ate species-speciﬁc secondary HRP-conjugated antibody. Proteins
were detected using the ECL system (Amersham, UK).
RESULTS
Staurosporine induced apoptosis in T47D and MCF-7
human breast cancer cells
Studies of apoptosis, as determined by DNA fragmentation (ISNT),
demonstrated that T47D and MCF-7 cells, when exposed to STS
(0.2–1 mM), exhibited a concentration-dependent increase in
apoptosis, with maximal effects for both cells being at 1 mM STS
(data not shown). Apoptosis was also a time-dependent process.
When exposed to 1 mM STS, a signiﬁcant increase in cells display-
ing DNA fragmentation was evident at 14 h in T47D cells, yet
apoptotic changes were detected as early as 4 h in MCF-7 cells
(Figure 1A). We further examined DNA fragmentation by cell
death ELISA. Results presented in Figure 1B show a time-depen-
dent increase in the presence of mono- and oligo-nucleosomes
similar to that observed with ISNT in both cell types, with
MCF-7 cells exhibiting greater levels of apoptosis. The apoptotic
effect was conﬁrmed by nuclear morphology (Figure 1C), with
both cell types showing smaller nuclei and chromatin condensation
resulting in the formation of crescent shapes around the periphery
of the nucleus. However, T47D cells displayed apoptotic body
formation although this was absent from MCF-7 cells (Figure
1C). Furthermore, plasma membrane changes, such as exposure
of phosphatidyl-serine (PS) residues to the outer surface of the
plasma membrane were evident during STS-induced apoptosis.
STS induced an increase in binding of annexin-V in MCF-7 cells
after 4 h of treatment and continued to increase, however this
occurred later in T47D cells where signiﬁcant annexin-V binding
was achieved 12 h after 1 mM STS (Figure 2). No changes in annex-
in-V binding were detected before 12 h in T47D cell (data not
shown). This demonstrates that plasma membrane changes prob-
ably occur just prior to DNA fragmentation in T47D cells
however, in MCF-7 cells these changes appear to occur simulta-
neously.
DNA fragmentation is mostly mediated by caspase-3 cleavage of
the inhibitory protein DFF45 resulting in release of the endonu-
clease DFF40 which is then free to cleave DNA (Enari et al,
1998; Wolf et al, 1999). It has been shown that MCF-7 cells lack
caspase-3 protein. Caspase-3 expression was also absent in the
MCF-7 cells used in this study, however we detected caspase-3
expression in T47D cells (data not shown). Therefore in contrast
recent studies where lack of DNA fragmentation in response to TNFa
and STS was reported (Janicke et al, 1998b), these results (Figure
3A) show that despite the absence of caspase-3, DNA fragmenta-
tion was detectable in MCF-7 cells.
Caspase involvement in staurosporine induced apoptosis of
T47D and MCF-7 breast cancer cells
To examine whether caspases were involved in STS induced apop-
tosis, cells were pre-incubated for 1 h with z-VAD-fmk, a broad
spectrum caspase inhibitor and were then treated for 16 h with
1 mM STS. As shown in Figure 3, z-VAD-fmk abrogated the apop-
totic effect of STS in both T47D and MCF-7 cells. This
demonstrates that STS-induced apoptosis requires activation of
the caspase family of proteases. We then examined the activity of
effector caspases ﬁrstly using the substrate DEVD which is the
recognition site for caspases-3 and -7. There was no signiﬁcant
increase in DEVDase activity in MCF-7 cells at 12 and 24 h of
treatment implying lack of involvement of caspase-7 since these
cells do not express caspase-3 (Figure 3B). However, in T47D cells
a time-dependent increase in DEVDase was observed from 12 h of
treatment, which reaches maximal levels at 48 h implying involve-
ment of caspase-3 and/or -7 in these cells (Figure 3B).
Effector caspase-6 was analysed by assessing disappearance of the
full length protein by Western blotting. Levels of pro-caspase-6
protein did not alter in response to STS in T47D cells (Figure
3C). In contrast, in MCF-7 cells, pro-caspase-6 levels decreased
following treatment with STS at 16 and 24 h (Figure 3C). There-
fore, STS, appeared to induce a time dependent increase in
caspase-3 or -7 activity in T47D cells and activation of caspase-6
in MCF-7 cells.
Activation of the caspase cascade leads to cleavage of cellular
proteins such as the DNA repair enzyme poly-ADP-ribose poly-
merase (PARP); cleavage results in inactivation of the enzyme.
STS induced PARP cleavage in a time-dependent manner in
MCF-7 cells; the 85 kDa cleavage product was observed as early
as 3 h after treatment and this increased dramatically by 16 h
(Figure 4A). PARP cleavage was abrogated on pre-treatment
with z-VAD-fmk (Figure 4A). However, in T47D cells PARP
cleavage was not detectable until 24 and 48 h of treatment,
however only partial cleavage was evident; the level of full
length protein 48 h after treatment was similar to that of
control cells (Figure 4B). PARP cleavage was also inhibited by
z-VAD-fmk in T47D cells.
Staurosporine induces a reduction in the mitochondrial
transmembrane potential (DCm) and release of
cytochrome c in T47D and MCF-7 human breast cancer
cells
Alterations in the mitochondrial transmembrane potential (DCm)
have been shown to be important for the release of mitochondrial
proteins such as cytochrome c, which when in the cytosol can lead
to activation of the caspase cascade and subsequent death (Reed,
1997). We measured the mitochondrial transmembrane potential
(DCm) by staining with 40 nM DiOC6(3) after treatment with
1 mM STS. STS caused a time-dependent reduction in the mito-
chondrial transmembrane potential (DCm) in MCF-7 and T47D
cells (Figure 5A). In MCF-7 cells this was signiﬁcant 3 h after treat-
ment whereas signiﬁcant changes were not observed until 8 h in
T47D cells (Figure 5A). At each time point the majority of cells
were PI negative implying this mitochondrial alteration occurs
before any membrane changes. Moreover, Mitotracker Red staining
at these time points was low and diffuse (data not shown),
substantiating a reduction in DCm after STS treatment. To verify
that the breakdown of DCm is an early event during STS induced
apoptosis and was not subsequent to caspase activation, we tested
the effect of z-VAD-fmk on the loss of DCm. Cells were pre-incu-
bated with z-VAD-fmk and then treated with 1 mM STS for 6 h. As
shown in Figure 6B, z-VAD-fmk had no effect on the reduction in
DCm at 6 h in either T47D or MCF-7 cells, suggesting this effect
to be caspase-independent. To determine the effect of STS on cyto-
chrome c release, cytosolic extracts were assessed by Western
blotting. The results show that cytochrome c release was observed
at 2 h after STS treatment in MCF-7 cells and 4 h after treatment
in T47D cells (Figure 6A,B). Cytochrome c oxidase subunit II was
used as a mitochondrial marker. Cytochrome c oxidase was not
detected in any cytosolic extracts (Figure 6A,B) demonstrating no
mitochondrial contamination. The data suggest that mitochondrial
dependent mechanisms contribute to STS mediated apoptosis in
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apoptotic pathway.
Effect of Staurosporine on Bcl-2, Bcl-xL Bak and Bax
protein expression and Bax localisation in human breast
cancer cells
There are numerous studies suggesting that overexpression of Bcl-2
or Bcl-xL can block apoptosis by effects at the mitochondrion
(Shimizu et al, 1996; Susin et al, 1997; Yang et al, 1997), whereas
Bax and Bak have been shown to exert pro-apoptotic activity
(Chittenden et al, 1995; Narita et al, 1998). We examined the effect
of STS on the expression levels of Bcl-2, Bcl-xL, Bak and Bax
proteins. In MCF-7 and T47D cells STS did not alter Bcl-2, Bcl-
xL, Bax nor Bak protein expression from 3 to 24 h (MCF-7 cells)
or 6 to 48 h (T47D cells) of treatment (data not shown). Bcl-2
expression in T47D cells was not detected by Western blotting,
which is in agreement with a previous report (Zapata et al,
1998). Therefore STS mediated apoptosis in T47D and MCF-7 cells
does not involve alterations in the expression of Bcl-2, Bcl-xL, Bak
or Bax proteins.
Bax translocation from the cytosol to the mitochondria has been
demonstrated to occur in many cell lines in response to a variety of
apoptotic inducers (Hsu et al, 1997; Gross et al, 1998). In order to
determine the localisation of Bax in MCF-7 and T47D cells we
exposed cells to 1 mM STS then prepared cytosolic fractions. As
shown in Figure 7, Bax protein levels decrease with time in the
cytosolic extracts of MCF-7 and T47D cells, 3 and 8 h after treat-
ment respectively. This is consistent with Bax translocating to the
mitochondria after treatment with STS and that this occurs follow-
ing the release of cytochrome c in both cell types, and also that this
redistribution is an early event in these cells preceding PARP clea-
vage and caspase activation.
DISCUSSION
Many chemotherapeutic drugs have been shown to induce apopto-
sis in various cancer types. It is therefore important to understand
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Figure 1 Staurosporine induced apoptosis in T47D and MCF-7 human breast cancer cells. (A) Cells were treated with 1 mM STS for the times indicated
and apoptosis was determined by DNA fragmentation (ISNT) on ﬁxed and permeabilised cells. Data are presented as per cent DNA fragmentation: error
bars represent the mean+s.e.m. of three independent experiments. (B) Cells were treated with 1 mM STS for the times indicated, lysates were analysed by
ELISA according to the manufacturer’s instructions. Fold induction in apoptosis is expressed as amount of cytoplasm DNA-histone complexes in treated cells
compared to untreated controls. Error bars represent the mean+s.e.m. of three independent experiments where * indicates statistically signiﬁcant increase
in apoptosis compared to untreated control (0 h), (ANOVA: F=5.44, P50.05, d,f 2,9. Tukey multiple comparison test, P50.05). (C) Apoptotic nuclear
morphology. (i) T47D cells (ii) MCF-7 cells. Cells were treated with 1 mM STS for 16 h, then washed in PBS, ﬁxed, permeabilised and stained with 1 mgm l
71
DAPI. Cells were then analysed by ﬂuorescent microscopy.
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Figure 2 Staurosporine induced a time dependent increase in annexin-V binding in (A) T47D and (B) MCF-7 cells. Both T47D and MCF-7 cells were
treated with 1 mM STS for the times indicated. Cells were washed in PBS and stained with annexin-V-FITC and PI and analysed by Flow Cytometry. Cells
staining annexin-V-FITC+/PI- were considered apoptotic; cells staining annexin-V-FITC+/PI+ were classiﬁed as late apoptotic/necrotic. Data are presented
as per cent of cells in each classiﬁcation. Error bars represent the mean+s.e.m. of three independent experiments.
70
60
50
40
30
20
10
0
%
 
D
N
A
 
f
r
a
g
m
e
n
t
a
t
i
o
n
T47D
MCF-7
MCF-7
T47D
0.4
0.35
0.3
0.25
0.2
0.15
0.1
0.05
0
A
b
s
o
r
b
a
n
c
e
 
(
4
0
5
 
n
m
)
C STS Z-VAD Z-VAD+
STS 0              12              24             48
Time (h)
MCF-7
Caspase 6
*
A B
Time (h)
Time (h)
T47D
C 6 16 24 48
Caspase 6
C 3  61 6 2 4
C
Figure 3 Staurosporine induced apoptosis activation of the caspase cascade in both MCF-7 and T47D cells. (A) Cells were pre-incubated with 100 mM z-
VAD-fmk (Z-VAD) for 1 h prior to the addition of 1 mM STS for 16 h. Cells were ﬁxed, permeabilised and DNA fragmentation detected by ISNT. Error
bars represent the mean+s.e.m. of three independent experiments. (B) Cells were treated for different time periods with 1 mM STS. Cell lysates were
prepared and incubated with Ac-DEVD-pNA (caspase-3/7). The reaction products were measured at 405 nm after a 4 h incubation. Error bars represent
the mean+s.e.m. of four independent experiments where * indicates statistically signiﬁcant increase in DEVDase activity compared to untreated control
(0 h), (ANOVA: F=3.38, P50.05, d,f 3,12. Tukey multipe comparison test, P50.05). (C) Full length caspase-6 protein is cleaved in MCF-7 but not in T47D
cells after treatment. Cells were treated with 1 mM STS for indicated times, lysates prepared and 50 mg protein subjected to SDS–PAGE followed by Wes-
tern transfer and probed with caspase-6 antibody. C indicates untreated cells. The results are representative of three independent experiments.
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ã 2002 Cancer Research UK British Journal of Cancer (2002) 87(8), 909–917how each drug acts to induce apoptosis on certain cancers. Staur-
osporine has been shown to induce apoptosis in many cell types
including, cardiomyocytes (Yue et al, 1998), chang liver cells
(Swe and Sit, 1997), ﬁbroblasts (Jacobson et al, 1996) and Jurkat
T cells (Takahashi et al, 1997). Here we studied its effect and
mechanisms of action on breast cancer cells. T47D and MCF-7
cells both underwent apoptosis in response to STS. MCF-7 cells
were more sensitive to STS than T47D cells, and the onset of apop-
totic events was different, with MCF-7 cells appearing to respond
to STS induced apoptosis earlier. Maximal apoptosis was achieved
24 h after exposure to 1 mM STS in MCF-7 cells whereas this was
48 h in T47D cells. DNA fragmentation is an endpoint character-
istic of apoptosis occurring after caspase activation. DFF45 is an
inhibitor of an endonuclease DFF40. Once DFF45 is cleaved by
caspases, DFF40 is then active and free to cause DNA fragmenta-
tion. Recent studies have suggested that caspase-3 and -7 and no
other caspase so far identiﬁed are essential to cleave DFF45 and
result in active DFF40 (Liu et al, 1999), and that caspase-3 was
essential for DNA fragmentation in MCF-7 cells (Tang and Kidd,
1998; Zapata et al, 1998). However, as the MCF-7 cells used in
the present study did not express caspase-3 protein, the possibility
existed that caspase-7 might substitute for caspase-3. Indeed, our
results show DNA fragmentation in both cell types was completely
inhibited by z-VAD-fmk implying this effect to be caspase
mediated. However, DEVDase activity was not detected in MCF-
7 cells in response to STS suggesting that caspase-7 is not involved.
Therefore, we suggest that in MCF-7 cells another mechanism
exists, which is a caspase-3 independent pathway causing the
DNA fragmentation observed in this study. Many studies have
utilised MCF-7 cells to study apoptosis and have demonstrated
DNA fragmentation in response to many stimuli (Saunders et al,
1997; Hishikawa et al, 1999; Tudor et al, 2000). For example, nitric
oxide induced apoptosis in MCF-7 cells with a lack of DEVDase
activity substantiating the suggestion for an alternative mechanism
in MCF-7 and possibly other cells that do not express caspase-3
(Umansky et al, 2000). More recently it has been demonstrated
that in the absence of caspase-3 in MCF-7 cells, DNA fragmenta-
tion did not occur and cytochrome c release was slower
compared to caspase-3 expressing cells (Blanc et al, 2000). Also
caspase-9 processing was impaired in response to cisplatin in
MCF-7 cells. Such different ﬁndings to our results could be due
to the difference in the variants of MCF-7 cells used. There have
been many studies highlighting the differences in MCF-7 cell
variants (Osborne et al, 1987; Burow et al, 1998; Gooch and Yee,
1999) by illustrating the differences in DNA fragmentation in
response to a variety of apoptotic stimuli. Yet it is clear that, in
the absence of caspase-3, MCF-7 cells do undergo caspase-3 inde-
pendent DNA fragmentation. Indeed, caspase-3 7/7 hepatocytes
and thymocytes do display DNA fragmentation although, with
delayed kinetics compared to caspase-3 +/+ cells (Zheng et al,
1998). This also points to an alternative mechanism independent
of DFF45/DFF40 in caspase-3 deﬁcient cells. In this study, DNA
fragmentation was inhibited by z-VAD-fmk implying that another
caspase is involved. Recent cloning of DFF45/ICAD homologues
(Inohara et al, 1998) raise the possibility that other DFF45/
DFF40 complexes exist which can be activated independently of
caspase-3. Indeed, in support of this idea it has been demonstrated
that, in the absence of caspase-3, hepatocyte cells induce compen-
satory caspase activation, such as caspase-6 (Zheng et al, 2000).
This could also be the case for MCF-7 cells, as we have shown that
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Figure 4 Staurosporine induced PARP cleavage in MCF-7 and T47D
cells. Both (A) MCF-7 and (B) T47D cells were either treated with
1 mM STS for the times indicated or pre-incubated with 100 mM z-VAD-
fmk for 1 h prior to STS treatments. Cell lysates (40 mg protein) were pre-
pared and samples subjected to 8% SDS–PAGE followed by Western
transfer and probed with PARP antibody (full length protein is 113 kDa,
and cleaved fragment is 85 kDa). The results are representative of three
independent experiments.
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Figure 5 Alterations of the mitochondrial transmembrane potential
(DCm) in MCF-7 and T47D cells in response to STS. (A) Cells were trea-
ted with 1 mM STS for the times indicated. Cells were then stained with
40 nM DiOC6(3). Representative histoplots are shown for each time point.
The dotted line separates cells with high and low ﬂuorescence. (B) Caspase
independent DCm collapse. Cells were incubated with 100 mM z-VAD-fmk
(Z-VAD) prior to 1 mM STS for 6 h. Mean ﬂuorescence (FL-1) representing
DCm was measured by Flow Cytometry. Error bars represent the mean+
s.e.m. of four independent experiments.
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illustrate redundancy within the caspase family of proteases.
Although caspase-6 processing was detected in MCF-7 cells, full
length protein was still present at 24 h. Caspase-6 processing has
been shown to require caspase-9 and caspase-3; therefore in the
absence of caspase-3 this could explain why partial processing
was observed. In T47D cells, DEVDase activity was detected imply-
ing the classical pathway leading to cleavage of DFF45 and
subsequent DNA fragmentation occurs. In addition, T47D cells
displayed typical apoptotic morphology yet in MCF-7 cells apopto-
tic body formation was absent. Apoptotic body formation involves
p21 activated kinase (PAK2) which when cleaved becomes consti-
tutively active and has been demonstrated to be a substrate of
caspase-3 (Rudel and Bokoch, 1997). In the absence of caspase-3,
PAK2 would not be activated and this could account for the
abnormal apoptotic morphology in MCF-7 cells. Proteolytic
processing of PARP was detected at 3 h in MCF-7 cells yet changes
in caspase-6 were not observed until 16 h. However, release of
cytochrome c into the cytoplasm leads to the formation of an
apoptosome, which is a complex of dATP, cytochrome c, Apaf-1
and procaspase-9 that results in activation of caspase-9. PARP is
also a substrate for caspase-9 therefore the activation of caspase-
9, could account for the early cleavage of PARP in MCF-7 cells.
In T47D cells only partial PARP cleavage was observed at 24 and
48 h of treatment which was coincident with DEVDase activity
in these cells.
Mitochondrial changes were observed in both MCF-7 and
T47D cells but again with different kinetics. We have demon-
strated cytochrome c release from the mitochondria to the
cytosol in both MCF-7 and T47D cells at 2 and 4 h respectively.
Cytochrome c release from mitochondria that occurs after STS
treatment is possibly controlled by Bax. Bax has been shown
to be cytosolic and in association with intracellular membranes
including the mitochondrial membrane, but upon apoptotic
stimuli Bax inserts into the mitochondrial membrane and leads
to the release of cytochrome c (Goping et al, 1998). It has also
been shown that Bax redistribution occurs in cells at different
times (Wolter et al, 1997). In MCF-7 and T47D cells, Bax
protein levels declined in the cytosol at 3 and 8 h respectively
after treatment, which was subsequent to cytochrome c release.
It is therefore possible that, in these cells, sufﬁcient Bax resides
at the mitochondrial membrane to induce cytochrome c release
after a death signal, and further apoptotic insult leads to increas-
ing amounts of Bax translocating to the mitochondria. This
could explain why we do not observe signiﬁcant changes in
Bax protein translocation until 3 and 8 h after STS exposure,
although it does not rule out Bax being responsible for cyto-
chrome c release. In addition to triggering cytochrome c
release, Bax induces a reduction in the mitochondrial transmem-
brane potential (DCm). This was observed at 3 h in MCF-7 cells
and 6 h in T47D cells, and occurred coincident with signiﬁcant
Bax translocation. In both cases, the release of cytochrome c into
the cytosol preceded the loss of DCm, which is consistent with a
caspase independent mechanism upstream of the mitochondria.
Loss of DCm has been postulated to involve opening of a large
permeability transition pore (PTP). This would suggest that in
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Figure 6 Staurosporine induced cytochrome c release into the cytosol of (A) MCF-7 and (B) T47D cells. After treatment with 1 mM STS for the times
indicated cytosolic extracts were prepared and 30 mg protein subjected to 14% SDS–PAGE followed by Western blot analysis with anti-cytochrome c
antibody (Cyt c) and cytochrome c oxidase subunit II (Cyt Ox). Whole cell lysate (WCL) was used as a positive control for the cytochrome c oxidase.
Results are representative of four independent experiments.
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Figure 7 Staurosporine induced Bax redistribution from the cytosol to the mitochondria in breast cancer cells (A) MCF-7 (B) T47D. After incubation
with 1 mM STS for the indicated times cytosolic extracts were prepared and subjected to 14% SDS–PAGE followed by Western blot analysis and probed
with anti-Bax or anti cytochrome c oxidase subunit II antibody. Also shown are the Bax levels in the whole cell lysate of (C) MCF-7 and (D) T47D cells
respectively. Results are representative of three independent experiments.
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dently of PTP opening.
Taken together, our data demonstrate that the mechanism of
STS mediated activation of different caspase cascades in T47D
and MCF-7 cells involved the release of cytochrome c, loss of
DCm and Bax redistribution. Interestingly, despite the lack of
caspase-3, MCF-7 cells proceeded to apoptosis more rapidly. Also,
the lag time between the earliest event observed (cytochrome c
release) and morphological and biochemical evidence of apoptosis
(ISNT, annexin V) was longer in T47D cells (around 8 h) than in
the caspase-3 deﬁcient MCF-7 cells (around 1–2 h). This study
provides further evidence for the existence of another mechanism
of DNA fragmentation in the absence of caspase-3. However, we
have also shown that two similar tumour types undergo STS
induced apoptosis with similar outcomes, but with very different
kinetics, and emphasising that pathways to apoptosis can be very
different in similar cell types. Such variations may have relevance
to tumour progression in a clinical setting since cell may respond
differently to chemotherapy, and perhaps also to survival factors.
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